T. Millar

发表

Graphene Oxide-Upconversion Nanoparticle Based Optical Sensors for Targeted Detection of mRNA Biomarkers Present in Alzheimer's Disease and Prostate Cancer.

O. Muskens, T. Brown, A. Kanaras, 2017, ACS sensors.

Exocytosis of peptide functionalized gold nanoparticles in endothelial cells.

S. Nitti, A. Kanaras, D. Bartczak, 2012, Nanoscale.

Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions

R. Eisenthal, N. Benjamin, T. Millar, 1998, FEBS letters.

Vascular physiology and pathology of circulating xanthine oxidoreductase: from nucleotide sequence to functional enzyme

T. Millar, C. Stevens, J. Hewinson, 2004, Redox report : communications in free radical research.

In vitro and ex vivo evaluation of the biological performance of 1 sclerosing foams

M. Hill, D. Carugo, T. Millar, 2019 .

Nanoparticles for inhibition of in vitro tumour angiogenesis: synergistic actions of ligand function and laser irradiation.

Otto L Muskens, Dorota Bartczak, Simone Nitti, 2015, Biomaterials science.

Human Endothelial Cells Modulate CD4+ T Cell Populations and Enhance Regulatory T Cell Suppressive Capacity

E. Healy, T. Millar, M. Olding, 2018, Front. Immunol..

Temporal Monitoring of Differentiated Human Airway Epithelial Cells Using Microfluidics

D. Davies, J. Collins, T. Millar, 2015, PloS one.

Peroxynitrite formation from the simultaneous reduction of nitrite and oxygen by xanthine oxidase

T. Millar, 2004, FEBS letters.

Xanthine oxidase can generate nitric oxide from nitrate in ischaemia.

T. Millar, C. Stevens, D. Blake, 1997, Biochemical Society transactions.

ROS generation in endothelial hypoxia and reoxygenation stimulates MAP kinase signaling and kinase-dependent neutrophil recruitment.

T. Millar, V. Phan, L. Tibbles, 2007, Free radical biology & medicine.

Xanthine Oxidase Mediates Cytokine-induced, but not Hormone-induced Bone Resorption

J. Kanczler, T. Millar, C. Stevens, 2003, Free radical research.

Free radicals in rheumatoid arthritis: Mediators and modulators

J. Kanczler, T. Millar, C. Stevens, 2003 .

Xanthine oxidase is a peroxynitrite synthase: newlyidentified roles for a very old enzyme

J. Kanczler, T. Millar, C. Stevens, 2002, Redox report : communications in free radical research.

Physical Vein Models to Quantify the Flow Performance of Sclerosing Foams

M. Hill, A. Lewis, D. Carugo, 2019, Front. Bioeng. Biotechnol..

Foam-in-vein: A review of rheological properties and characterization methods for optimization of sclerosing foams.

A. Lewis, D. Carugo, S. Jones, 2020, Journal of biomedical materials research. Part B, Applied biomaterials.

Foam-in-Vein: Characterisation of Blood Displacement Efficacy of Liquid Sclerosing Foams

A. Lewis, D. Carugo, S. Jones, 2022, Biomolecules.

Xanthine oxidase: four roles for the enzyme in rheumatoid pathology.

M. Benboubetra, J. Kanczler, T. Millar, 1997, Biochemical Society transactions.

Mycobacterium tuberculosis subverts negative regulatory pathways in human macrophages to drive immunopathology

Shuye Tian, C. Proud, S. Jogai, 2017, PLoS pathogens.

Blockade of KATP Channels Reduces Endothelial Hyperpolarization and Leukocyte Recruitment upon Reperfusion After Hypoxia

W. Giles, P. Kubes, L. Chilton, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Foam-in-Vein: Rheological Characterisation of Liquid Sclerosing Foams Using a Pipe Viscometer

A. Lewis, D. Carugo, S. Jones, 2022, Colloids and Surfaces A: Physicochemical and Engineering Aspects.

In vitro and ex vivo evaluation of the biological performance of sclerosing foams

M. Hill, A. Lewis, D. Carugo, 2019, Scientific Reports.

XANTHINE DEHYDROGENASE FROM GENE TO PROTEIN

T. Millar, C. Stevens, J. Hewinson, 2004 .

Cellular crosstalk between airway epithelial and endothelial cells regulates barrier functions during exposure to double‐stranded RNA

Matthew Loxham, Timothy M. Millar, Marie Held, 2017, Immunity, inflammation and disease.

Interactions of human endothelial cells with gold nanoparticles of different morphologies.

Otto L Muskens, Dorota Bartczak, Simone Nitti, 2012, Small.

Receptor-mediated interactions between colloidal gold nanoparticles and human umbilical vein endothelial cells.

Dorota Bartczak, Tilman Sanchez-Elsner, A. Kanaras, 2011, Small.

Manipulation of in vitro angiogenesis using peptide-coated gold nanoparticles.

Otto L Muskens, Dorota Bartczak, Tilman Sanchez-Elsner, 2013, ACS nano.

Nanoparticulate drugs for the manipulation of angiogenesis.

A. Kanaras, T. Millar, 2013, Therapeutic delivery.

"We engineered peptide-coated gold nanospheres, nanorods and hollow nanoparticles, and employed them to initially manipulate the functions of endothelial cells and consequently angiogenesis."

T. Millar, 2013 .

Functional nanoparticles in cells

Antonios G. Kanaras, Dorota Bartczak, Otto L. Muskens, 2012, BiOS.

Gold nanoparticles in biomedical applications

Antonios G. Kanaras, Dorota Bartczak, Otto L. Muskens, 2011, BiOS.

Laser-induced damage and recovery of plasmonically targeted human endothelial cells.

Otto L Muskens, Dorota Bartczak, Tilman Sanchez-Elsner, 2011, Nano letters.

Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase.

N. Benjamin, T. Millar, S. O’Byrne, 2000, The Journal of pharmacology and experimental therapeutics.

Furosemide in the Treatment of Phosgene Induced Acute Lung Injury

T. Millar, P. Rice, B. Jugg, 2010, Journal of the Royal Army Medical Corps.

Nanoparticles for inhibition of in vitro tumour angiogenesis: synergistic actions of ligand function and laser irradiation.

O. Muskens, A. Kanaras, D. Bartczak, 2015, Biomaterials science.